These effects, along with a former report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two support the strategy of focusing on ACKR3 as a unique approach to modulate the opioid process, which could open new therapeutic avenues for opioid-related disorders. Besides the described previously mentioned https://garryi622znt4.ssnblog.com/profile